Baseline neutrophil-to-lymphocyte ratio as a predictor of response to hospitalized bronchiectasis exacerbation risks

References

• Chang AB, Bell SC, Byrnes CA, et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. A position statement from the thoracic society of Australia and New Zealand and the Australian lung foundation. Med J Aust. 2010;193(6):356–8. doi: 10.5694/j.1326-5377.2010.tb03949.x
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Oscullo G, Gomez-Olivas JD, et al. Bronchiectasis: changes in the characterization of patients during 20 years of follow-up. Data from the Spanish bronchiectasis registries. Arch Bronconeumol. 2023;59(10):688–690. doi: 10.1016/j.arbres.2023.07.023
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Aliberti S, Polverino E, et al. The EMBARC European bronchiectasis registry: protocol for an international observational study. ERJ Open Res. 2016;2(1):00081–2015. doi: 10.1183/23120541.00081-2015
   PubMedGoogle Scholar
• Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576–585. doi: 10.1164/rccm.201309-1575OC
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Smith MP, Bj M, et al. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non–cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2012;186(7):657–665. doi: 10.1164/rccm.201203-0487OC
   PubMed Web of Science ®Google Scholar
• Kapur N, Masters IB, Chang AB. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability? Chest. 2010;138(1):158–164. doi: 10.1378/chest.09-2932
   PubMed Web of Science ®Google Scholar
• Polverino E, Goeminne PC, McDonnell MJ, et al. European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):50. doi: 10.1183/13993003.00629-2017
   Web of Science ®Google Scholar
• Sheehan RE, Wells AU, Copley SJ, et al. A comparison of serial computed tomography and functional change in bronchiectasis. Eur Respir J. 2002;20(3):581–587. doi: 10.1183/09031936.02.00284602
   PubMed Web of Science ®Google Scholar
• Seitz AE, Olivier KN, Steiner CA, et al. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest. 2010;138(4):944–949. doi: 10.1378/chest.10-0099
   PubMed Web of Science ®Google Scholar
• Ringshausen FC, de Roux A, Pletz MW, et al. bronchiectasis-associated hospitalizations in Germany, 2005–2011: a population-based study of disease burden and trends. PLOS ONE. 2013;8(8):e71109. doi: 10.1371/journal.pone.0071109
   PubMed Web of Science ®Google Scholar
• McDonnell MJ, Aliberti S, Goeminne PC, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016;4(12):969–979. doi: 10.1016/S2213-2600(16)30320-4
   PubMed Web of Science ®Google Scholar
• Beijers RJ, van den Borst B, Newman AB, et al. A multidimensional risk score to predict all-cause hospitalization in community-dwelling older individuals with obstructive lung disease. J Am Med Dir Assoc. 2016;17(6):508–513. doi: 10.1016/j.jamda.2016.01.007
   PubMed Web of Science ®Google Scholar
• Chan SC, Leung VO, Ip MS, et al. Shed syndecan-1 restricts neutrophil elastase from α 1 -antitrypsin in neutrophilic airway inflammation. Am J Respir Cell Mol Biol. 2009;41(5):620–628. doi: 10.1165/rcmb.2008-0185OC
   PubMed Web of Science ®Google Scholar
• Bedi P, Davidson DJ, McHugh BJ, et al. Blood neutrophils are reprogrammed in bronchiectasis. Am J Respir Crit Care Med. 2018;198:880–890. doi: 10.1164/rccm.201712-2423OC
   PubMed Web of Science ®Google Scholar
• Finch S, Shoemark A, Dicker AJ, et al. Pregnancy zone protein is associated with airway infection, neutrophil extracellular trap formation, and disease severity in bronchiectasis. Am J Respir Crit Care Med. 2019;200(8):992–1001. doi: 10.1164/rccm.201812-2351OC
   PubMed Web of Science ®Google Scholar
• Keir HR, Shoemark A, Dicker AJ, et al. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study. Lancet Respir Med. 2021;9(8):873–884. doi: 10.1016/S2213-2600(20)30504-X
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Olveira C, Giron R, et al. Peripheral neutrophil-to-lymphocyte ratio in bronchiectasis: a marker of disease severity. Biomolecules. 2022;12(10):12. doi: 10.3390/biom12101399
   Web of Science ®Google Scholar
• Coban H, Gungen AC. Is there a correlation between new scoring systems and systemic inflammation in stable bronchiectasis? Can Respir J. 2017;2017:9874068. doi: 10.1155/2017/9874068
   PubMed Web of Science ®Google Scholar
• Georgakopoulou VE, Trakas N, Damaskos C, et al. Neutrophils to lymphocyte ratio as a biomarker in bronchiectasis exacerbation: a retrospective study. Cureus. 2020;12:e9728. doi: 10.7759/cureus.9728
   PubMed Web of Science ®Google Scholar
• Nacaroglu HT, Erdem SB, Karaman S, et al. Can mean platelet volume and neutrophil-to-lymphocyte ratio be biomarkers of acute exacerbation of bronchiectasis in children? Cent Eur J Immunol. 2017;42(4):358–362. doi: 10.5114/ceji.2017.72808
   PubMed Web of Science ®Google Scholar
• Feng J, Sun L, Sun X, et al. Increasing prevalence and burden of bronchiectasis in urban Chinese adults, 2013–2017: a nationwide population-based cohort study. Respir Res. 2022;23(1):111. doi: 10.1186/s12931-022-02023-8
   PubMed Web of Science ®Google Scholar
• Ringshausen FC, Rademacher J, Pink I, et al. Increasing bronchiectasis prevalence in Germany, 2009–2017: a population-based cohort study. Eur Respir J. 2019;54(6):54. doi: 10.1183/13993003.00499-2019
   Web of Science ®Google Scholar
• Aliberti S, Goeminne PC, O’Donnell AE, et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med. 2022;10(3):298–306. doi: 10.1016/S2213-2600(21)00277-0
   PubMed Web of Science ®Google Scholar
• Cheung KS, Leung WK, Seto WK. Application of big data analysis in gastrointestinal research. World J Gastroenterol. 2019;25(24):2990–3008. doi: 10.3748/wjg.v25.i24.2990
   PubMed Web of Science ®Google Scholar
• Doring G, Conway SP, Heijerman HG, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J. 2000;16(4):749–767. doi: 10.1034/j.1399-3003.2000.16d30.x
   PubMed Web of Science ®Google Scholar
• Ip MS, Ko FW, Lau AC, et al. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest. 2006;129(2):384–392. doi: 10.1378/chest.129.2.384
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Athanazio RA, Giron R, et al. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Int J Chron Obstruct Pulmon Dis. 2017;12:275–284. doi: 10.2147/COPD.S121943
   PubMed Web of Science ®Google Scholar
• Yang B, Han K, Kim B, et al. Association between smoking status and incident non-cystic fibrosis bronchiectasis in young adults: a nationwide population-based study. J Pers Med. 2022;12(5):12. doi: 10.3390/jpm12050691
   Web of Science ®Google Scholar
• Forget P, Khalifa C, Defour JP, et al. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10(1):12. doi: 10.1186/s13104-016-2335-5
   PubMedGoogle Scholar
• Calixte R, Ye Z, Haq R, et al. Demographic and social patterns of the mean values of inflammatory markers in U.S. Adults: a 2009–2016 NHANES analysis. Diseases. 2023;11(1):11. doi: 10.3390/diseases11010014
   PubMedGoogle Scholar
• El-Gazzar AG, Kamel MH, Elbahnasy OKM, et al. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients. Expert Review of Respiratory Medicine. 2020;14(1):111–116. doi: 10.1080/17476348.2019.1675517
   PubMed Web of Science ®Google Scholar
• Furutate R, Ishii T, Motegi T, et al. The neutrophil to lymphocyte ratio is related to disease severity and exacerbation in patients with chronic obstructive pulmonary disease. Intern Med. 2016;55(3):223–229. doi: 10.2169/internalmedicine.55.5772
   PubMed Web of Science ®Google Scholar
• Karauda T, Kornicki K, Jarri A, et al. Eosinopenia and neutrophil-to-lymphocyte count ratio as prognostic factors in exacerbation of COPD. Sci Rep. 2021;11(1):4804. doi: 10.1038/s41598-021-84439-8
   PubMed Web of Science ®Google Scholar
• Lu FY, Chen R, Li N, et al. Neutrophil-to-lymphocyte ratio predicts clinical outcome of severe acute exacerbation of COPD in frequent exacerbators. Int J Chron Obstruct Pulmon Dis. 2021;16:341–349. doi: 10.2147/COPD.S290422
   PubMed Web of Science ®Google Scholar
• Zinellu A, Zinellu E, Pau MC, et al. A comprehensive systematic review and meta-analysis of the association between the neutrophil-to-lymphocyte ratio and adverse outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease. J Clin Med. 2022;11(12):11. doi: 10.3390/jcm11123365
   Web of Science ®Google Scholar
• Mikolasch TA, George PM, Sahota J, et al. Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis. EClinicalMedicine. 2023;55:101758. doi: 10.1016/j.eclinm.2022.101758
   PubMedGoogle Scholar